| Term 
 | Definition 
 
        | Systole- contraction Diastole- relaxation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SA Node AV Node
 Bundle of His
 Purkinje System
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Positive charge outside of cell |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Na & Ca flow in, K flows out |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta 1- positive chronotropic and inotropic effects 
 Alpha 1- vessel constriction
 
 Beta 2- vessel dilation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Increasing HR Increasing SV
 Increasing efficiency of muscle
 Physiologic enlargement
 |  | 
        |  | 
        
        | Term 
 
        | Disorders that respond to pharmacologic therapy |  | Definition 
 
        | valvular disease 
 cardiac arrhythmias
 
 myocardial disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Control rhythm 
 Maintain or increase output
 
 relieve fluid accumulation
 
 increase oxygenation
 |  | 
        |  | 
        
        | Term 
 
        | positive inotropic drug qualities |  | Definition 
 
        | Pros- improve strength of contraction 
 cons- increase 02 demand of heart
 May damage contractile tissue
 may increase occurrence of arrythmias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | positive inotropic digitalis derivative
 pros-improved cardio contractility, decrease HR, antiarrhythmia effects, decrease dyspnea
 
 Primary Action- increase force of contraction, decrease rate of contraction, improve baroreceptor function
 
 Clinical use-CHF, atrial fib, Sv tachycardia
 
 forms-digoxin (injectable, tabs, caps, elixir)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Positive inotropic 
 Sympathomimetic
 
 actions: increase force/rate of contraction, constrict peripheral blood vessel, elevate blood glucose
 
 con: short serum half lives
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | catecholamine/positive inotropic 
 uses: cardiac resuscitation, tx anaphylaxis
 
 forms: 1:10000 or 1:1000
 
 cons: hypertension, arrhythmias, anxiety, excitability
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | catecholamine/positive inotropic 
 use: tx of acute heart failure, oliguric renal failure, tx of shock
 
 cons: vomiting, tachycardia, dyspnea, variations in bp
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Positive inotropic 
 IV
 
 Short term
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Positive inotropic 
 Oral
 
 Long term
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | positive inotropic 
 av insufficiency or dilated myocardiopathy
 
 cons: anorexia, lethargy, diarrhea
 
 CTX: hypertrophic cardiomyopathy, aortic stenosis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class IA NA channel blocker 
 antiarrhytmic
 
 use: vent arrhythmias, tachy, a fib
 
 cons: anorexia, v/d, hypotension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IA NA channel blocker 
 premature vent contractions, vent tachy, some forms of attach
 
 cons: anorexia, v/d, hypotension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class IB Na channel blocker 
 use: control of pvc's, vtach
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | class II beta adrenergic blocker 
 antiarrhythmic
 
 tx: hypertrophic cardiomyopathy, arrhythmias, hypertension
 
 cons: bradycardia, hypotension, worsen heart failure, bronchospasm, lethargy, depression
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IV Ca channel blocker 
 antiarrhythmic
 
 use: supraventricular tach, atrial flutter, fib
 
 cons: hypotension, bradycardia, tachycardia, pulmonary edema, worsening CHF
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | vasodilator 
 arterial
 
 use: reduce afterload w/CHF, esp caused by mitral insufficiency
 
 cons: hypotension, v/d, Na& water retention &tach
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | venodilator 
 reduce preload & pulmo edema
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | aa&vv dilator 
 use: tx of CHF, dilated cardio in dogs, systemic & pulmonary hypertens
 
 cons: hypotension, syncope, v/d
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Combined vasodilators 
 tx of class II, III, IV heart failure
 
 captopril, enalapril
 
 cons: azotemia, BUN & creatinine rise
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diuretic 
 most efficient for removing edema w/heart failure
 
 cons: hypokalemia, dehydration, hyponatremia, ototoxicity (cats), weakness, shock
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diuretic 
 POTASSIUM SPARING
 
 normally used w/other diuretic
 |  | 
        |  |